Michael J. Kerin

32.2k total citations · 2 hit papers
432 papers, 14.6k citations indexed

About

Michael J. Kerin is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Michael J. Kerin has authored 432 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Cancer Research, 136 papers in Oncology and 124 papers in Molecular Biology. Recurrent topics in Michael J. Kerin's work include Breast Cancer Treatment Studies (84 papers), MicroRNA in disease regulation (68 papers) and Breast Lesions and Carcinomas (50 papers). Michael J. Kerin is often cited by papers focused on Breast Cancer Treatment Studies (84 papers), MicroRNA in disease regulation (68 papers) and Breast Lesions and Carcinomas (50 papers). Michael J. Kerin collaborates with scholars based in Ireland, United Kingdom and United States. Michael J. Kerin's co-authors include Nicola Miller, Aoïfe Lowery, Helen Heneghan, Karl Sweeney, Róisín M. Dwyer, James A. L. Brown, John Newell, Ronan W. Glynn, Timothy O’Brien and Andrew McGuire and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Michael J. Kerin

414 papers receiving 14.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer principles and practice of oncology

1997 562 citations Michael J. Kerin profile →
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

2010 557 citations Helen Heneghan, Nicola Miller et al. profile →

Peers

Countries citing papers authored by Michael J. Kerin

Since Specialization

Citations

This map shows the geographic impact of Michael J. Kerin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Kerin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Kerin more than expected).

Fields of papers citing papers by Michael J. Kerin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Kerin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Kerin. The network helps show where Michael J. Kerin may publish in the future.

Co-authorship network of co-authors of Michael J. Kerin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Kerin. A scholar is included among the top collaborators of Michael J. Kerin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Kerin. Michael J. Kerin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic performance of the second-generation Wavelia microwave breast imaging system: a pilot clinical investigation 2025 ·British journal of surgery ·(unknown), (unknown), Sami Abd Elwahab, Tom Butler, (unknown), (unknown), (unknown), (unknown), Luc Duchesne, (unknown), Aoïfe Lowery, Michael J. Kerin	0
2	STRATEGIES FOR PRODUCING CLINICAL AND COMMERCIAL RNA-LNP DRUG PRODUCTS 2024 ·Cytotherapy ·Samuel Clarke, (unknown), (unknown), Richard S. Young, Michael J. Kerin, Darshan Singh, (unknown), Bo Ma, Ana Lazic, Xuhui Lee, Christine Robin, (unknown), Pierrot Harvie, Suraj Abraham	4
3	Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer 2023 ·Journal of Clinical Medicine ·Michael J. Cronin, (unknown), Matthew G. Davey, Peter G. Ryan, Mahmoud Abdelshafy, (unknown), Hesham Elzomor, Shahram Arsang‐Jang, (unknown), P Nash, James J. Crowley, (unknown), Andrew J. Simpkin, Aoïfe Lowery, William Wijns, Michael J. Kerin, Osama Soliman	9
4	Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials 2023 ·BJS Open ·Matthew G. Davey, (unknown), (unknown), (unknown), (unknown), Stewart R. Walsh, Michael J. Kerin, Aoïfe Lowery	1
5	Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Matthew G. Davey, (unknown), Nicola Miller, Michael J. Kerin	5
6	The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis 2022 ·European Journal of Radiology ·(unknown), (unknown), (unknown), (unknown), Aoïfe Lowery, (unknown), (unknown), Michael J. Kerin, (unknown)	16
7	MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer 2022 ·Cancers ·Matthew G. Davey, (unknown), Heidi Annuk, (unknown), Emma Holian, Aoïfe Lowery, Michael J. Kerin, Nicola Miller	16
8	Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis 2022 ·Breast Cancer Research and Treatment ·Matthew G. Davey, (unknown), John P. O’Donnell, (unknown), Aoïfe Lowery, Michael J. Kerin	7
9	What Proportion of Systematic Reviews and Meta-Analyses Published in the Annals of Surgery Provide Definitive Conclusions—A Systematic Review and Bibliometric Analysis 2022 ·Publications ·Matthew G. Davey, Martin S. Davey, Aoïfe Lowery, Michael J. Kerin	0
10	Intra-operative nerve monitoring and recurrent laryngeal nerve injury during thyroid surgery: a network meta-analysis of prospective studies 2022 ·Langenbeck s Archives of Surgery ·(unknown), Matthew G. Davey, (unknown), Aoïfe Lowery, Michael J. Kerin	8
11	Analysis of sentinel node positivity in primary cutaneous melanoma: an 8-year single institution experience 2017 ·Irish Journal of Medical Science (1971 -) ·Kieran Joyce, Niall McInerney, (unknown), Francisco Martín‐Luján, (unknown), (unknown), Michael J. Kerin, Jack Kelly, Padraic Regan	4
12	Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype 2017 ·Annals of Surgical Oncology ·(unknown), Aoïfe Lowery, Malcolm Kell, Michael J. Kerin, Karl Sweeney	40
13	A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis 2011 ·The Lancet Oncology ·Trupti Paranjape, Helen Heneghan, Robert Lindner, Florence K. Keane, Aaron E. Hoffman, Antoinette Hollestelle, (unknown), (unknown), (unknown), Sunitha Nallur, John W.M. Martens, Maartje J. Hooning, Michael J. Kerin, Daniel Zelterman, Yongxue Zhu, David Tuck, Lyndsay N. Harris, Nicola Miller, Frank J. Slack, Joanne B. Weidhaas	101
14	Malignant Phyllodes Tumour with Liposarcomatous Differentiation, Invasive Tubular Carcinoma, and Ductal and Lobular Carcinoma In Situ: Case Report and Review of the Literature 2010 ·Pathology Research International ·(unknown), Francis Sullivan, Michael J. Kerin, Grace Callagy	17
15	Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics 2010 ·Breast Cancer Research and Treatment ·Elrasheid A. H. Kheirelseid, (unknown), Nicola Miller, Catherine Curran, Karl Sweeney, Carmel Malone, (unknown), John Newell, Michael J. Kerin	105
16	Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy 2010 ·Annals of Surgical Oncology ·Ronan W. Glynn, Nicola Miller, Maria Whelan, Michael J. Kerin	12
17	Estrogen Induces Repression of the Breast Cancer and Salivary Gland Expression Gene in an Estrogen Receptor α–Dependent Manner 2008 ·Cancer Research ·Nancy Bretschneider, Heike Brand, Nicola Miller, Aoïfe Lowery, Michael J. Kerin, Frank Gannon, Stefanie Denger	23
18	Breast 10–21 2004 ·British journal of surgery ·Malcolm Kell, Daniel R. Lucey, Peter J. Holloway, M. Kennedy, (unknown), T. F. Gorey, T. P. Corrigan, Michael J. Kerin, Dara O. Kavanagh, Arnold Hill, (unknown), Cecily Quinn, Fergal J. Fleming, Alasdair F. O’Doherty, Chris Collins, E. McDermott, N. J. O’Higgins	0
19	Utilisation of serum VEGF to predict curative colorectal cancer resections 1997 ·Gut ·(unknown), K Heer, (unknown), John Greenman, G. S. Duthie, Michael J. Kerin, J. R. T. Monson	1
20	Combined endoscopic cytology and biopsies in the diagnosis of duodenal malignancy 1990 ·International Journal of Clinical Practice ·Alistair King, John P. McCabe, (unknown), Michael J. Kerin, Margaret McGuire, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact